Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Insurance, Health, Reimbursement"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
dewey-ones:"330 - Economics"
Showing
1
-
20
of
87
Search:
'"Insurance, Health, Reimbursement"'
,
query time: 0.02s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian Drug Expert Committee recommendation: Sodium zirconium cyclosilicate (Lokelma -- Astrazeneca Canada Inc.) : indication: hyperkalemia
Published 2020
CADTH
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
2
CADTH Canadian Drug Expert Committee recommendation: Fluticasone Propionate (Aermony respiclick -- Teva Canada Innovation) : indication : maintenance treatment of asthma in patient...
Published 2018
CADTH
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
3
CADTH Canadian Drug Expert Committee recommendation: Fluticasone Propionate (Aermony respiclick -- Teva Canada Innovation) : indication : maintenance treatment of asthma in patient...
Published 2018
CADTH
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
4
CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
5
CADTH Canadian Drug Expert Committee recommendation: Cysteamine delayed-release (Procysbi -- Horizon Pharma Ireland Ltd.) : indication : nephropathic cystinosis
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
6
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (Orfadin -- Sobi Canada Inc.) : indication: the treatment of adult and pediatric patients with hereditary tyrosinemi...
Published 2018
CADTH
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
7
CADTH Canadian Drug Expert Committee recommendation: Edaravone (Radicava -- Mitsubishi Tanabe Pharma Corporation) : indication : for the treatment of amyotrophic lateral sclerosis
Published 2019
CADTH
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
8
CADTH Canadian Drug Expert Committee recommendation: Tafamidis meglumine (Vyndaqel - Pfizer Canada ULC) : indication : for the treatment of adult patients with cardiomyopathy due t...
Published 2020
CADTH
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
9
CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
10
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication : adult patients with active psoriatic arthritis (PsA) who have respon...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
11
CADTH Canadian Drug Expert Committee recommendation: Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (Symtuza -- Janssen Inc.) : indication: treatment of HIV type 1 (HIV-1...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
/ economics...
”
Read Now
12
CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy
Published 2019
CADTH
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
13
CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy
Published 2019
CADTH
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
14
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication : adult patients with active psoriatic arthritis (PsA) who have respon...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
15
Pharmacoeconomic review report: Brexpiprazole (Rexulti) : (Lundbeck Canada Inc. and Otsuka Canada Pharmaceutical Inc.) : indication: treatment of schizophrenia in adults
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
/ economics...
”
Read Now
16
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (nitisinone tablets -- Cycle Pharmaceuticals Ltd.) : indication : the treatment of adult and pediatric patients with...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
17
CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
/ economics...
”
Read Now
18
CADTH Canadian Drug Expert Committee recommendation: Brexpiprazole (Rexulti - Lundbeck Canada Inc and Otsuka Canada Pharmaceutical Inc.) : indication : treatment of schizophrenia i...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
19
CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
/ economics...
”
Read Now
20
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (nitisinone tablets -- Cycle Pharmaceuticals Ltd.) : indication : the treatment of adult and pediatric patients with...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
1
2
3
4
5
Back
Narrow Search
Remove Filters
Clear Filter
Classification: 330 - Economics
Year of Publication
From:
To:
Classification
330 - Economics
610 - Medicine & health
87
140 - Specific philosophical schools
8
700 - The arts; fine & decorative arts
7
Language
English
87
Collection
National Center for Biotechnology Information
87
Author
CADTH Canadian Drug Expert Committee
84
Canadian Agency for Drugs and Technologies in Health
56
Abernethy, Amy Pickar
1
Duke University Evidence-based Practice Center
1
Technology Assessment Program (Agency for Healthcare Research and Quality)
1
United States Agency for Healthcare Research and Quality
1
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&lookfor=%22Insurance%2C+Health%2C+Reimbursement%22&type=Subject
Send by Email
×
Loading...